The single molecule bio-electronic
smart system array for clinical testing

Read more

Bio-electronic
sensing system
Single-molecule detection - sensitive
Cost-effective

Context of the project

ELISA after more than 40 years since its discovery, is still the most popular multiplexing assay to quantify protein bio-markers despite the performance level limited by multiple assay steps, low sensitivity and low dynamic range.

Digitizing biomarkers analysis by quantifying them at the single-molecule level is the new frontier for advancing the science of precision health. Such an occurrence will enormously enhance their ability of curing diseases by supporting better prognosis and permitting the application of precise treatment methods. An enormous improvement in the quality of life and longevity of the population for generations to come is foreseen along with a reduction of health care expenses.

The disruptive bio-electronic smart system developed in SiMBiT will open to a massive use of high-throughput array-based assay not only in clinical laboratory analysis, but also in point-of-care and low resources settings.

News

  • PARTICIPATION TO THE WORLD CONGRESS ON BIOSENSORS IN KOREA IN NOVEMBER 2020 03 August 2020

    We are pleased that SiMBiT project coordinator Luisa Torsi will be one of the plenary speaker at the...

    Read More ...

  • SiMBiT’S DEMONSTRATION OF THE SINGLE MOLECULE DETECTION THANKS TO SiMoT TECHNOLOGY 09 July 2020

    At the beginning of this year, part of the SiMBiT consortium published a paper on current...

    Read More ...

  • SiMBiT – First year activities and achievments 11 March 2020

    Already 14 months have passed since the beginning of the SiMBiT project. Now that the first year...

    Read More ...